Serum Institute Of India And Biocon

Rediff.com » News » Serum Institute Of India And Biocon

News for Serum Institute Of India And Biocon

News
Business

'No preparedness planning, no accountability, no action plan'

'This government did not have any plan for safety stocks of essential medicines.' IMAGE: Doctors attend to a patient suffering from COVID-19 inside the emergency room at the Safdarjung Hospital in......

Plasma therapy isn't proven treatment for COVID-19: Govt

The plasma therapy for treatment of coronavirus patients is at an experimental stage and it has the potential to cause life-threatening complications, the Union health ministry said on Tuesday,......

Biocon Biologics Plan Molecule Launch Every 1-2 Years

'The tie-up with Serum Institute Life Sciences brings to the table their strengths in manufacturing and also their vaccine portfolio.' Photograph: PTI Photo The market share that Biocon......

India's biotech export touches $1.2 billion

India's export revenue from biotechnology grew by 47 percent to reach 1.2 billion dollars in the financial year ended March 2007, a survey said.According to a survey conducted by the Association on......

India's richest club sees nine new entrants; Ambani still No 1

Half of the nation’s 100 richest saw gains rising a collective 14% to $517.5 billion, says Forbes. The Covid-19 pandemic may have hit India hard, but nine newcomers joined the ranks of......

Mukesh Ambani's wealth swells 73% to Rs 6.58 lakh cr

Gautam Adani, who is diversifying into many businesses, saw a 48 per cent rise in his wealth to Rs 1.40 lakh crore and moved up two places in rankings to being the fourth richest Indian. Hinduja......

'Budget's focus on 'Bharat' will create jobs'

'It is a balanced and prudent Budget that sets the foundation for future growth in the economy.' Illustration: Uttam Ghosh/Rediff.com India Inc said the 'Bharat' oriented Budget with a thrust on......

Serum Institute Of India And Biocon

News for Serum Institute Of India And Biocon

'No preparedness planning, no accountability, no action plan'

Plasma therapy isn't proven treatment for COVID-19: Govt

Biocon Biologics Plan Molecule Launch Every 1-2 Years

India's biotech export touches $1.2 billion

India's richest club sees nine new entrants; Ambani still No 1

Mukesh Ambani's wealth swells 73% to Rs 6.58 lakh cr

'Budget's focus on 'Bharat' will create jobs'

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS